 - For TNBC and solid tumors other than melanoma: GPNMB expression as defined by at least 25 of malignant epithelial cells or tumor stromal cells expression GPNMB at any intensity via central immunohistochemistry on archived or biopsied tumor tissue as per standard clinical care from an advancedmetastatic disease site; for melanoma or uveal melanoma cohort: GPNMB testing results will not be required for eligibility assessment 